CUE - Cue Biopharma, Inc.

📈 Is growth accelerating? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Revenue Growth YoY (%)	166.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1983%)	1250.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+15532%)	1292.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+16053%)	-35.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-545%)	11.1% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+39%)	-75.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1044%)	-13.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-268%)	58.9% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+636%)	92.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1054%)	818.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+10127%)	1106.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+13725%)	2988.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+37253%)	5215.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+65092%)	-81.3% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1116%)	-98.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1327%)	-97.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1315%)	-99.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1338%)	-35.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-545%)	1636.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+20357%)	240.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2902%)	154.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1835%)	72.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+807%)	-54.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-784%)	-28.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-456%)	1.9% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-76%)	143.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1691%)	217.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2617%)	119.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1389%)	513.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+6317%)	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	-804.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-535.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	58.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-1235.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	32.0% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	65.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	29.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	31.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	13.8% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	23.7% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	22.6% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	21.6% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	—	-52.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	24.4% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-1704.6% Weak ↓ Weak Declining Year-over-year change in net income	57.8% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	14.0% Fair ↓ Fair Declining Year-over-year change in net income	16.6% Good → Good Stable Year-over-year change in net income	0.7% Caution ↓ Caution Declining Year-over-year change in net income	29.3% Excellent ↑ Excellent Improving Year-over-year change in net income	21.3% Good ↑ Good Improving Year-over-year change in net income	22.9% Good ↑ Good Improving Year-over-year change in net income	5.8% Fair ↑ Fair Improving Year-over-year change in net income	7.9% Fair ↑ Fair Improving Year-over-year change in net income	-0.5% Weak ↑ Weak Improving Year-over-year change in net income	0.2% Caution ↑ Caution Improving Year-over-year change in net income	8.0% Fair ↑ Fair Improving Year-over-year change in net income	-74.0% Weak ↓ Weak Declining Year-over-year change in net income	15.7% Good ↑ Good Improving Year-over-year change in net income	-28.5% Weak ↓ Weak Declining Year-over-year change in net income	-14.0% Weak ↓ Weak Declining Year-over-year change in net income	24.5% Good ↑ Good Improving Year-over-year change in net income	-29.5% Weak ↓ Weak Declining Year-over-year change in net income	5.1% Fair ↑ Fair Improving Year-over-year change in net income	2.4% Caution ↑ Caution Improving Year-over-year change in net income	-24.5% Weak → Weak Stable Year-over-year change in net income	-43.5% Weak ↓ Weak Declining Year-over-year change in net income	-13.8% Weak ↓ Weak Declining Year-over-year change in net income	-13.8% Weak ↓ Weak Declining Year-over-year change in net income	23.3% Good ↑ Good Improving Year-over-year change in net income	44.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-30.4% Weak ↑ Weak Improving Year-over-year change in net income	-49.8% Weak ↑ Weak Improving Year-over-year change in net income	-11.3% Weak ↑ Weak Improving Year-over-year change in net income	-149.6% Weak ↓ Weak Declining Year-over-year change in net income	-65.4% Weak Weak Year-over-year change in net income	-124.6% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	-322.9% Weak Weak Year-over-year change in free cash flow	-1953.3% Weak Weak Year-over-year change in free cash flow	—	—	—	43.7% Excellent Excellent Year-over-year change in free cash flow	—	—	—	18.0% Good Good Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	78.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	212.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	425.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	216.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	384.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-25.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-42.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	11.7% Good ↓ Good Declining Compound annual revenue growth over 3 years	-1.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	3.4% Caution ↓ Caution Declining Compound annual revenue growth over 3 years	56.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	44.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	8.7% Fair ↑ Fair Improving Compound annual revenue growth over 3 years	-40.8% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-47.6% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-59.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-70.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	39.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	192.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	74.7% Excellent Excellent Compound annual revenue growth over 3 years	151.6% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	23.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	29.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	115.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	25.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	22.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-14.1% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	8.5% Good ↓ Good Declining Compound annual revenue growth over 5 years	27.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	20.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	35.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	40.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	36.1% Excellent Excellent Compound annual revenue growth over 5 years	51.7% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Operating Margin (%) (%)	—	-94.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-728%)	9.0% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-40%)	-353.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2456%)	-292.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2049%)	—	—	-264.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1862%)	-390.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2704%)	—	—	—	—	—	—	—	—	—	-95.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-737%)	—	-376.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2608%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-4.5% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	-91.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-859%)	7.2% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-40%)	-346.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2988%)	-287.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2493%)	—	—	-259.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2263%)	-382.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3289%)	—	—	—	—	—	—	—	—	—	-101.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-946%)	—	-375.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3227%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-368.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-194.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-4.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-419.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-116.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	-129.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-277.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-365.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.19x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	2.14x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-0.68x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.21x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.41x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.80x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.83x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.27x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.51x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.00x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.85x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.32x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.75x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.35x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.53x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.18x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Return on Invested Capital (%)	-2999.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	5.9% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	-45.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-37.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-147.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-43.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-26.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-34.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-30.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-26.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.9% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-14.6% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-17.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-14.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-22.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-26.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-47.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.0% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-10.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-13.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—
Return on Capital (%) (%)	-285.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	4.7% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	-24.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-55.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-29.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-24.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.6% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-18.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-15.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-9.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-14.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-21.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-22.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-25.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-24.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-12.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-15.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	—	-24.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-260%)	6.0% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-60%)	-56.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-475%)	-46.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-411%)	-186.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1342%)	-54.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-462%)	-34.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-328%)	-47.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-414%)	-41.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-374%)	-36.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-341%)	-25.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-272%)	-28.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-291%)	-23.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-259%)	-22.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-248%)	-21.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-244%)	-22.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-247%)	-22.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-247%)	-12.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-185%)	-20.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-236%)	-14.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-194%)	-17.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-220%)	-14.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-194%)	-11.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-176%)	-13.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-190%)	-28.3% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-289%)	-16.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-209%)	-25.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-272%)	-47.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-413%)	-45.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-404%)	-34.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-328%)	-31.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-312%)	-14.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-199%)	-13.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-191%)	-16.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-213%)	—	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Debt to Equity (x)	—	—	—	—	—	0.02x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-97%)	—	0.04x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-93%)	0.09x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-85%)	0.10x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-83%)	0.11x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-81%)	0.12x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-80%)	0.13x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-78%)	0.13x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-79%)	0.12x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-80%)	0.18x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-70%)	—	0.15x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-75%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	—	—	123.62x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-185.24x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-261.67x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-136.66x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-78.96x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-46.89x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-48.29x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-383.88x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-18.49x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-44.96x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-38.62x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-40.49x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1351.45x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-88.96x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-396.67x Weak Weak Operating income divided by interest expense Optimal: > 5x	-569.52x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-17.39M	$-16.38M	$-27.14M	$-11.70M	—	$-13.04M	$-22.46M	$-31.42M	$-28.03M	$-37.99M	$-44.31M	$-49.69M	$-46.90M	$-49.32M	$-43.58M	$-20.69M	—	$-58.07M	$-64.37M	—	—	$-73.26M	$-74.87M	$-71.73M	$-59.75M	$-23.43M	$-44.29M	—	$-24.26M	$-21.91M	$-20.80M	—	—	$-53.10M	—	$-3.40M	$-7.31M	$-14.93M	—
Debt / EBITDA (x)	—	—	—	—	—	-0.01x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.11x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.19x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.24x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.31x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.44x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.45x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.53x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.55x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.83x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.70x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Revenue per Share (USD)	$1.24	$1.18	—	$0.02	$0.93	$0.01	—	$0.07	$0.05	$0.03	—	$0.05	$0.03	$0.00	—	$0.00	$0.00	—	—	$0.08	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-24.14	$-1.08	$0.03	$-0.07	$-2.67	$-0.17	$-0.10	$-0.17	$-0.20	$-0.25	$-0.29	$-0.24	$-0.29	$-0.29	$-0.38	$-0.31	$-0.37	—	$-0.25	$-0.41	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-4.57	$-2.30	—	$-0.09	$-1.08	$-0.11	—	—	—	$-0.20	—	—	—	$-0.24	—	—	$-0.37	—	—	$-0.21	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.44	$6.64	$0.27	$0.17	$5.71	$0.11	$0.28	$0.42	$0.44	$0.62	$0.79	$0.95	$1.05	$1.27	$1.39	$1.43	$1.69	$1.89	$2.03	$2.03	—	$2.28	$2.60	$2.89	$2.74	$1.70	$2.05	—	$0.95	$1.19	$1.64	—	—	$2.74	$3.17	—	—	—	—
Tangible Book Value per Share (USD)	$0.44	$6.64	$0.27	$0.17	$5.71	$0.11	$0.28	$0.42	$0.44	$0.62	$0.79	$0.95	$1.05	$1.27	$1.39	$1.43	$1.69	$1.89	$2.03	$2.03	—	$2.28	$2.60	$2.89	$2.74	$1.70	$2.05	—	$0.95	$1.19	$1.64	—	—	$2.74	$3.17	—	—	—	—
Basic Weighted Avg Shares (shares)	6.34M	4.81M	—	100.87M	3.18M	74.25M	—	51.23M	50.17M	49.47M	—	46.36M	44.80M	44.65M	—	35.38M	35.36M	—	—	31.32M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Working Capital (USD)	$5.41M	$19.00M	$23.49M	$10.29M	—	$433.00K	$11.45M	$20.47M	$17.44M	$26.58M	$34.37M	$40.31M	$44.63M	$54.95M	$65.64M	$51.48M	—	$64.54M	$55.68M	—	—	$60.77M	$71.21M	$79.34M	$73.49M	$39.10M	$49.37M	—	$18.60M	$21.39M	$34.39M	—	—	—	$59.72M	—	—	—	—
LT Debt (USD)	—	—	—	—	—	—	—	$1.00M	$2.00M	$3.00M	$4.20M	$5.00M	$6.00M	$7.00M	$8.04M	$9.00M	—	$9.86M	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$2.31M	$21.61M	$26.43M	$13.25M	$18.16M	$6.58M	$17.50M	$25.37M	$21.62M	$30.04M	$37.09M	$42.67M	$46.00M	$55.02M	$65.68M	$50.76M	$59.76M	$64.67M	$65.49M	$63.52M	$72.91M	$69.67M	$78.91M	$87.55M	$80.15M	$45.24M	$54.58M	$27.02M	$20.28M	$24.74M	$33.97M	$39.40M	$49.23M	$55.24M	$61.61M	—	—	—	$15.17M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Sales/Revenue/Turnover (USD)	$7.88M	$5.69M	$21.94M	$2.15M	$2.95M	$421.00K	$1.58M	$3.34M	$2.66M	$1.72M	$1.82M	$2.10M	$1.38M	$187.00K	$151.00K	$68.00K	$26.00K	$1.00M	$8.25M	$2.40M	$2.74M	$1.55M	$475.32K	$704.00K	$1.07M	$900.00K	$1.05M	$984.00K	$1.05M	$370.00K	$330.60K	$449.00K	$172.00K	—	—	—	—	—	—
Depreciation Expense (USD)	$33.00K	$74.00K	$65.00K	$76.00K	$97.00K	$97.00K	$95.00K	$100.00K	$100.00K	$96.00K	$145.00K	$128.00K	$132.00K	$174.00K	$201.00K	$198.00K	$212.00K	$220.00K	$227.11K	$232.00K	$231.00K	$218.00K	$184.53K	$199.00K	$202.00K	$194.00K	$194.11K	$194.00K	$205.00K	$205.00K	$204.01K	$195.00K	$195.00K	$167.00K	$126.57K	$124.00K	$102.00K	$67.00K	—
Net Income, GAAP (USD)	$-153.07M	$-5.18M	$1.58M	$-7.45M	$-8.48M	$-12.26M	$-9.50M	$-8.66M	$-10.17M	$-12.35M	$-13.43M	$-11.01M	$-13.19M	$-13.11M	$-14.59M	$-10.96M	$-13.21M	$-14.26M	$-8.38M	$-12.99M	$-10.28M	$-12.51M	$-11.10M	$-10.03M	$-10.83M	$-12.82M	$-8.92M	$-6.99M	$-9.52M	$-11.27M	$-11.62M	$-12.56M	$-7.30M	$-7.52M	$-10.44M	$-5.03M	$-4.41M	$-3.35M	—
Operating Cash Flow (USD)	$-29.00M	$-10.94M	$-1.08M	$-9.02M	$-3.42M	$-8.17M	$-9.03M	—	—	$-9.78M	$-10.96M	—	—	$-10.83M	$-10.51M	—	$-12.85M	$-11.57M	$-10.65M	$-6.63M	$-9.77M	$-11.79M	$-7.00M	—	—	$-10.94M	$-6.44M	$-9.21M	—	$-8.47M	$-3.90M	$-6.30M	$-6.46M	—	$-1.85M	$-3.68M	—	—	—

Cue Biopharma, Inc.

Analytical Summary

39-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CUE with peers